Shanghai RAAS Blood Products Co., Ltd.
002252
Kedudukan dalam Saham
#3644
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Harga Saham
$0.70717976
Modal Pasaran
$4.66B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-24.71%
Negara
CN
Perdagangan Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
Bilangan saham terbitan bagi Shanghai RAAS Blood Products Co., Ltd. (002252)
Bilangan saham terbitan setakat June 2026: 6.59B
Menurut laporan kewangan terkini dan harga saham Shanghai RAAS Blood Products Co., Ltd., bilangan saham terbitan semasa ialah 6.59B. Pada akhir December 2023, syarikat mempunyai 6.59B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Shanghai RAAS Blood Products Co., Ltd. (002252) dari 2005 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 6.59B | -0.86% |
| 2024 | 6.65B | 0.84% |
| 2023 | 6.59B | -2.23% |
| 2022 | 6.74B | 0.00% |
| 2021 | 6.74B | 0.00% |
| 2020 | 6.74B | 33.07% |
| 2019 | 5.07B | 3.42% |
| 2018 | 4.90B | -0.38% |
| 2017 | 4.92B | 0.58% |
| 2016 | 4.89B | -1.38% |
| 2015 | 4.96B | 18.59% |
| 2014 | 4.18B | 12.08% |
| 2013 | 3.73B | 5.89% |
| 2012 | 3.52B | 0.73% |
| 2011 | 3.50B | -1.10% |
| 2010 | 3.54B | 0.54% |
| 2009 | 3.52B | 14.23% |
| 2008 | 3.08B | 16.19% |
| 2007 | 2.65B | 177.44% |
| 2006 | 954.93M | -0.19% |
| 2005 | 956.76M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 253.90M | -96.15% |
US
|
|
| 396.00M | -93.99% |
US
|
|
| 478.91M | -92.73% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -99.06% |
NL
|
